Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

Core Insights - Medtronic has received FDA clearance for the Stealth AXiS™ surgical system, which integrates surgical planning, navigation, and robotics for cranial and ENT procedures, enhancing precision and real-time insights for surgeons [1][2]. Group 1: Product Features and Capabilities - The Stealth AXiS™ system combines advanced navigation, robotics, and AI-enabled capabilities within the AiBLE™ smart ecosystem, providing deeper insights throughout the surgical workflow [2]. - The system features AI-based automatic tractography for cranial procedures, allowing surgeons to create patient-specific brain maps and visualize critical neural pathways [2]. - For ENT procedures, the system offers high-precision navigation and advanced visualization tailored to the complex anatomy of the sinuses and skull base, enhancing decision-making in the operating room [3][4]. Group 2: Market Position and Strategy - Medtronic's Cranial and Spinal Technologies business serves over 4 million patients annually with a portfolio of 150 products addressing more than 20 pathologies, emphasizing a patient-centric approach [6]. - The ENT business impacts nearly 3 million patients each year and has been a leader in surgical navigation for over 25 years, continuously advancing care through innovative technologies [7]. - The Stealth AXiS™ system is positioned as the next generation of navigation for ENT surgery, building on Medtronic's legacy of navigation leadership [5].